Versiti Acquires Indiana-Based Quantigen

Versiti, a national leader in blood health innovation, today announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. Further expanding Versiti's clinical trial expertise and service offering, Quantigen provides a range of services supporting preclinical and clinical research as well as clinical diagnostics. The Quantigen team specializes in assay development, biomarker validation, and diagnostic regulatory filings for a wide range of methods and disease states. The Quantigen team is particularly proud of ongoing partnerships with NGOs to adapt existing diagnostic technologies for use in lower- and middle-income countries to address significant unmet diagnostic and health needs in these communities.